OraSure Technologies logo

OraSure TechnologiesNASDAQ: OSUR

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 November 1986

Next earnings report:

02 August 2024

Last dividends:

N/A

Next dividends:

N/A
$301.75 M
-68%vs. 3y high
60%vs. sector
-92%vs. 3y high
21%vs. sector
-70%vs. 3y high
34%vs. sector
-76%vs. 3y high
23%vs. sector

Price

after hours | 16 min ago
$4.08-$0.19(-4.45%)

Dividend

No data over the past 3 years
$54.13 M$52.01 M
$54.13 M-$3.58 M

Analysts recommendations

Institutional Ownership

OSUR Latest News

OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
Seeking Alpha27 February 2024 Sentiment: POSITIVE

OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript

OraSure to Participate in Upcoming Investor Conferences
GlobeNewsWire13 November 2023 Sentiment: POSITIVE

BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the company is scheduled to participate in the following investor conferences:

OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates
Zacks Investment Research07 November 2023 Sentiment: POSITIVE

OraSure Technologies (OSUR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.

OraSure Technologies (OSUR) Reports Q2 Loss, Tops Revenue Estimates
Zacks Investment Research03 August 2023 Sentiment: NEUTRAL

OraSure Technologies (OSUR) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to break-even earnings per share a year ago.

OraSure Technologies: As Good As It Gets
Seeking Alpha15 May 2023 Sentiment: POSITIVE

Today, we take our first look at OraSure Technologies, Inc., which has seen a huge and recent surge of revenues. However, this was almost entirely due to Covid-related sales which are projected to fall dramatically in the quarters ahead.

OraSure Technologies, Inc. (OSUR) Q1 2023 Earnings Call Transcript
Seeking Alpha10 May 2023 Sentiment: POSITIVE

OraSure Technologies, Inc. (NASDAQ:OSUR ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Scott Gleason - Head of Investor Relations Carrie Manner - President & Chief Executive Officer Ken McGrath - Chief Financial Officer Conference Call Participants Casey Woodring - JPMorgan Operator Good day, and thank you for standing-by. Welcome to the OraSure Technologies Earnings Conference Call.

OraSure Technologies (OSUR) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research10 May 2023 Sentiment: POSITIVE

OraSure Technologies (OSUR) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to loss of $0.28 per share a year ago.

2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET
GlobeNewsWire03 May 2023 Sentiment: POSITIVE

BETHLEHEM, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 first quarter financial results and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Wednesday, May 10, 2023.

Is OraSure Technologies (OSUR) Outperforming Other Medical Stocks This Year?
Zacks Investment Research21 April 2023 Sentiment: POSITIVE

Here is how OraSure Technologies (OSUR) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year.

OraSure (OSUR) Stock Jumps 9.3%: Will It Continue to Soar?
Zacks Investment Research05 April 2023 Sentiment: POSITIVE

OraSure (OSUR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

What type of business is OraSure Technologies?

OraSure Technologies, Inc. is an American company founded in 1986, headquartered in Bethlehem, Pennsylvania, USA. The company is involved in the development, manufacturing, promotion, and sale of oral fluid diagnostic devices and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests used for different types of specimens. The company operates in two segments: OSUR and DNAG. The OSUR segment includes the development, manufacturing, and sale of diagnostic products, specimen collection devices, and medical devices. The DNAG segment, or molecular diagnostics segment, primarily consists of the development, manufacturing, and sale of devices for collecting oral fluid specimens.

What sector is OraSure Technologies in?

OraSure Technologies is in the Healthcare sector

What industry is OraSure Technologies in?

OraSure Technologies is in the Medical Instruments & Supplies industry

What country is OraSure Technologies from?

OraSure Technologies is headquartered in United States

When did OraSure Technologies go public?

OraSure Technologies initial public offering (IPO) was on 17 November 1986

What is OraSure Technologies website?

https://www.orasure.com

Is OraSure Technologies in the S&P 500?

No, OraSure Technologies is not included in the S&P 500 index

Is OraSure Technologies in the NASDAQ 100?

No, OraSure Technologies is not included in the NASDAQ 100 index

Is OraSure Technologies in the Dow Jones?

No, OraSure Technologies is not included in the Dow Jones index

When does OraSure Technologies report earnings?

The next expected earnings date for OraSure Technologies is 02 August 2024